Search Results

Displaying Results 1-1 of 1 "'KYN'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Cognision Announces Partnership with Kynexis to Utilize its COGNISION® System in a Phase 2 Trial of <em>KYN</em>-5356 in Subjects with Schizophrenia

Nov 14, 2025, 10:32 ET Cognision Announces Partnership with Kynexis to Utilize its COGNISION® System in a Phase 2 Trial of KYN-5356 in Subjects with Schizophrenia

neurobiomarker technology, announces its partnership with Kynexis to utilize the COGNISION® System in Kynexis' Phase 2 clinical trial of KYN-5356 in subjects with schizophrenia.

More news about: Cognision

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.